 NEW YORK , July 27, 2022 PRNewswire -- Delcath Systems, Inc. Nasdaq: DCTH, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on August 8, 2022, at 8:30 AM Eastern Time to discuss results for its second quarter ended June 30, 2022. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. 